Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Beyond glomeruli: interstitial fibrosis and tubular atrophy predict poor renal outcomes in lupus nephritis.

Arthritis research & therapy·2026
Same author

Urinary Chemokines in the Diagnosis and Monitoring of Immune Checkpoint Inhibitor-Associated Nephritis.

International journal of molecular sciences·2026
Same author

In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis.

American journal of physiology. Cell physiology·2025
Same author

Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study.

Pharmaceutics·2025
Same author

Clinical Burden and Costs of Anti-Neutrophil Cytoplasmic Antibody-ANCA-Associated Vasculitis: Main Findings from REDCap Registry of a University Hospital in Spain.

ClinicoEconomics and outcomes research : CEOR·2025

Related Experiment Video

Updated: Jun 7, 2025

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

6.8K

Immune checkpoint molecules performance in ANCA vasculitis.

Paula Anton-Pampols1,2, Laura Martinez Valenzuela3,2, Loreto Fernandez Lorente4,5

  • 1Nephrology, Bellvitge University Hospital, L'Hospitalet de Llobregat, Spain.

RMD Open
|November 13, 2024
PubMed
Summary

Immune checkpoint (IC) molecules, including PD-1, show altered levels in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). Urinary PD-1 and PD-L2 are lower in AAV patients, while serum levels are higher, suggesting a role in disease activity.

Keywords:
AutoimmunitySystemic vasculitisVasculitis

More Related Videos

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.7K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Related Experiment Videos

Last Updated: Jun 7, 2025

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

6.8K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.7K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Area of Science:

  • Immunology
  • Nephrology
  • Autoimmunity

Background:

  • The PD-1 axis is crucial for preventing autoimmunity.
  • The role of immune checkpoint (IC) molecules in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is not well understood.
  • Understanding IC molecules in AAV could reveal new therapeutic targets and biomarkers.

Purpose of the Study:

  • To investigate the role of the IC pathway, specifically PD-1, PD-L1, and PD-L2, in the pathophysiology of AAV.
  • To assess IC molecule concentrations in serum, urine, and peripheral blood mononuclear cells (PBMCs) of AAV patients compared to healthy controls.
  • To analyze the expression of PD-1 and PD-L1 in kidney biopsies of AAV patients.

Main Methods:

  • Collected serum, urine, and PBMCs from 88 AAV patients (discovery cohort) and 30 healthy controls (HC).
  • Validated findings in an external cohort of 30 AAV patients.
  • Measured PD-1, PD-L1, and PD-L2 concentrations using a multiplex assay and analyzed PD-1/PD-L1 expression in kidney biopsies.

Main Results:

  • Urinary PD-1 (uPD-1) and PD-L2 (uPD-L2) were lower in AAV patients than HC, with lower uPD-L2 in acute AAV versus remission.
  • PBMCs showed reduced PD-1 production in AAV patients.
  • Serum PD-1 (sPD-1) and PD-L1 (sPD-L1) were higher in AAV patients than HC, with elevated sPD-1 in acute AAV versus remission.
  • Kidney biopsy analysis revealed fewer PD-1-positive cells in inflammatory lesions compared to sclerotic lesions.

Conclusions:

  • The study suggests a potential abolition of the IC pathway during active AAV, which is restored during remission.
  • Findings indicate that the PD-1 axis plays a significant role in AAV pathophysiology.
  • The PD-1 axis may serve as a novel biomarker for assessing AAV disease activity.